Acyclovir in cytomegalovirus infection 3 1/2 years after renal transplantation. An unusual case and dramatic response.

Late cytomegalovirus (CMV) infection in renal allograft recipients is uncommon. The treatment of CMV infection is controversial, with numerous claims of successful treatment with different drugs. We report the successful use of acyclovir in a serious case of CMV infection occurring in a young woman 3 1/2 years after a renal transplant. This result is encouraging and supports the future use of acyclovir in the treatment of CMV infection in this and other settings.